Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins

Kirsi H. Pietiläinen, Aila Rissanen, Jaakko Kaprio, Sari Mäkimattila, Anna‐Maija Häkkinen, Jukka Westerbacka, Jussi Sutinen, Satu Vehkavaara, Hannele Yki‐JärvinenAmerican 2004 · DOI

TL;DR

This study leverages monozygotic (MZ) twins to disentangle the effects of acquired obesity from genetics on metabolic health. They found that increased intra-abdominal and liver fat, along with insulin resistance, are directly linked to acquired obesity, even in genetically identical individuals. This highlights the significant role of environmental factors and lifestyle in developing metabolic dysfunction.

What Problem Does This Paper Address?

Understanding the root causes of obesity and its associated metabolic complications, like insulin resistance and fatty liver disease, is crucial. While genetics plays a role in body weight regulation, it's also clear that environmental factors and lifestyle choices significantly contribute to the rising rates of obesity. However, it's been challenging to definitively separate the influence of shared genetics from acquired lifestyle factors. Previous studies have shown correlations between fat distribution (especially visceral fat) and insulin resistance, and more recently, fatty liver has emerged as a key player in metabolic dysfunction. This paper aims to address this by using a powerful model: monozygotic (MZ) twins who share identical genes but can differ in their acquired characteristics, specifically body weight. By comparing MZ twins who are discordant (one is obese, the other is not) versus concordant (both are similar in weight) for obesity, the researchers can isolate the impact of acquired obesity on fat accumulation in the liver and abdomen, and on insulin sensitivity, independent of genetic predispositions.

Methods

The study employed a multi-pronged approach to assess body composition, fat distribution, and insulin sensitivity.

  • Body Composition and Fat Distribution:
    • Magnetic Resonance Imaging (MRI): Used to precisely measure the volume of intra-abdominal and subcutaneous adipose tissue. This is a standard, non-invasive technique for visualizing and quantifying fat depots.
  • Dual-energy X-ray Absorptiometry (DXA): Employed to determine whole-body fat percentage. DXA is a well-established method for assessing body composition.
  • Liver Fat Content:
    • Proton Spectroscopy (¹H-MRS): A specialized MRI technique used to quantify the amount of intracellular triglycerides in the liver. This allows for a non-invasive assessment of hepatic steatosis (fatty liver).
  • Insulin Sensitivity:
    • Euglycemic Insulin Clamp Technique: The gold standard for measuring whole-body insulin sensitivity. This involves infusing insulin and glucose at controlled rates to maintain a constant blood glucose level, with the glucose infusion rate reflecting insulin sensitivity.
  • Fasting Insulin Concentration: Measured as a surrogate marker for hepatic insulin sensitivity, as it's known to correlate with the liver's ability to suppress glucose production in response to insulin.

The study design specifically focused on comparing measurements within MZ twin pairs, particularly those discordant for BMI, to control for genetic background.

Datasets

The study utilized data from the FinnTwin16 cohort, a longitudinal population-based study of Finnish twins. Participants were recruited from this existing cohort. No new datasets were introduced or created for this study.

Key Insights and Ideas

  • Acquired Obesity Drives Metabolic Dysfunction: The most significant insight is the clear demonstration that acquired obesity, even in the presence of identical genetics, leads to increased intra-abdominal and liver fat, and impaired insulin sensitivity. This strongly supports the role of lifestyle and environmental factors over genetics in the development of these metabolic issues.
  • Intra-abdominal Fat as a Key Mediator: The study highlights the strong correlation between increased intra-abdominal fat and both BMI and insulin resistance. This reinforces the "portal hypothesis" suggesting that visceral fat's proximity to the liver and its contribution to circulating free fatty acids play a critical role in hepatic insulin resistance.
  • Liver Fat's Independent Contribution: While intra-abdominal fat is a major contributor, the study also shows that liver fat itself is significantly increased in acquired obesity and correlates with insulin resistance, even after accounting for intra-abdominal fat. This suggests liver fat has a distinct, independent role in metabolic health.
  • MZ Twin Discordance is a Powerful Tool: The use of MZ twin pairs discordant for obesity proved highly effective in isolating the effects of acquired factors. By comparing siblings who share genes but differ in weight, the researchers could confidently attribute observed metabolic differences to weight gain rather than genetic predispositions.

Key Results

  • Fat Distribution Differences: In discordant MZ twin pairs, the heavier cotwin had significantly more intra-abdominal fat (93% more) and subcutaneous fat (64% more) than their leaner sibling.
  • Liver Fat Accumulation: The heavier cotwins also exhibited a substantial increase in liver fat (284% more) compared to their leaner counterparts.
  • Insulin Resistance: Heavier cotwins in discordant pairs showed significantly lower whole-body insulin sensitivity (M-values) and higher fasting insulin levels compared to their leaner siblings.
  • Correlations:
    • Intrapair differences in BMI were strongly correlated with differences in intra-abdominal fat (r=0.82) and liver fat (r=0.57).
  • Intrapair differences in fasting insulin were correlated with intra-abdominal fat (r=0.75) and liver fat (r=0.49).
  • Whole-body insulin sensitivity (M-value) was negatively correlated with subcutaneous abdominal fat (r=-0.72) and intra-abdominal fat (r=-0.55), but not significantly with liver fat.
  • Concordant Twins: In contrast, concordant MZ twin pairs showed no significant differences in fat distribution or insulin sensitivity, underscoring the role of acquired differences.

Limitations and Future Work

  • Sample Size: The study identified only 14 pairs discordant for BMI (difference ≥ 4 kg/m²) out of 658 MZ pairs screened. This relatively small sample size for the discordant group might limit the generalizability of some findings.
  • Dietary Intake Nuances: While dietary intake was assessed, the study notes that the 3-day food diary method is prone to underreporting, especially in overweight individuals. Furthermore, correlations between specific dietary components and obesity/metabolic markers were not consistently strong, suggesting other acquired factors might be at play.
  • Causality vs. Correlation: While the study design strongly suggests causality, the authors acknowledge that the observed associations do not definitively prove a cause-and-effect relationship. Obesity is a complex condition with many intertwined metabolic alterations.
  • Future Directions: The authors suggest that further research could explore the precise mechanisms by which intra-abdominal and liver fat contribute to insulin resistance. Investigating other acquired factors beyond diet, such as physical activity and stress, could also provide a more complete picture. The study also points to the potential role of adiponectin deficiency and local cortisol production in adipose tissue as contributing factors to insulin resistance, which could be areas for further investigation.

Summary updated

Abstract

We determined whether acquired obesity is associated with increases in liver or intra-abdominal fat or impaired insulin sensitivity by studying monozygotic (MZ) twin pairs discordant and concordant for obesity. We studied nineteen 24- to 27-yr-old MZ twin pairs, with intrapair differences in body weight ranging from 0.1 to 24.7 kg [body mass index (BMI) range 20.0-33.9 kg/m2], identified from a population-based FinnTwin16 sample. Fat distribution was determined by magnetic resonance imaging, percent body fat by dual-energy X-ray absorptiometry, liver fat by proton spectroscopy, insulin sensitivity by measuring the fasting insulin concentration, and whole body insulin sensitivity by the euglycemic insulin clamp technique. Intrapair differences in BMI were significantly correlated with those in intra-abdominal fat (r = 0.82, P < 0.001) and liver fat (r = 0.57, P = 0.010). Intrapair differences in fasting insulin correlated with those in subcutaneous abdominal (r = 0.60, P = 0.008), intra-abdominal (r = 0.75, P = 0.0001) and liver (r = 0.49, P = 0.048) fat. Intrapair differences in whole body insulin sensitivity correlated with those in subcutaneous abdominal (r = -0.72, P = 0.001) and intra-abdominal (r = -0.55, P = 0.015) but not liver (r = -0.20, P = 0.20) fat. We conclude that acquired obesity is associated with increases in intra-abdominal and liver fat and insulin resistance, independent of genetic factors.
BibTeX
@inproceedings{pietilainen2004acquired,
  author = {Kirsi H. Pietiläinen and Aila Rissanen and Jaakko Kaprio and Sari Mäkimattila and Anna‐Maija Häkkinen and Jukka Westerbacka and Jussi Sutinen and Satu Vehkavaara and Hannele Yki‐Järvinen},
  title = {{Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins}},
  booktitle = {American},
  year = {2004},
  doi = {10.1152/ajpendo.00381.2004},
}
Figure